Tvardi Therapeutics (TVRD) Change in Inventory (2022 - 2024)
Tvardi Therapeutics (TVRD) posted Change in Inventory of $729000.0 for Q4 2024, up 72800.0% sequentially from $1000.0 in Q3 2024, and up 263.82% YoY from $200373.7 in Q1 2024.
Tvardi Therapeutics (TVRD) Change in Inventory (2022 - 2024) Analysis & Trends
Tvardi Therapeutics has reported Change in Inventory for 3 years, with the latest figure at $729000.0 in Q4 2024.
- Quarterly Change in Inventory rose 263.82% year-over-year to $729000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.0 million (up 137.9% YoY) and the FY2024 annual result came in at $1.0 million, up 137.9% from the prior year.
- Change in Inventory rose to $729000.0 in Q4 2024 per TVRD's latest filing, from $1000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $1.6 million in Q2 2022 and troughed at -$1.6 million in Q3 2022.
- A 3-year average of $106583.3 and a median of -$39500.0 in 2024 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory plunged 181.2% in 2023, then soared 512.63% in 2024.
- Over 3 years, Change in Inventory stood at $548000.0 in 2022, then slumped by 181.2% to -$445000.0 in 2023, then soared by 263.82% to $729000.0 in 2024.
- According to Business Quant data, Change in Inventory over the past three periods registered $729000.0, $1000.0, and $392000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 729,000.00 |
| Dec 31, 2024 | 729,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 392,000.00 |
| Jun 30, 2024 | 392,000.00 |
| Mar 31, 2024 | -80,000.00 |
| Mar 31, 2024 | -80,000.00 |
| Dec 31, 2023 | -445,000.00 |
| Dec 31, 2023 | -445,000.00 |
| Sep 30, 2023 | -154,000.00 |
| Sep 30, 2023 | -154,000.00 |
| Jun 30, 2023 | -95,000.00 |
| Jun 30, 2023 | -95,000.00 |
| Mar 31, 2023 | 1.13 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 548,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | -1.63 Mn |
| Sep 30, 2022 | -1.63 Mn |